Real-world operation of multiple sclerosis centres in Central-Eastern European countries covering 107 million inhabitants
Zsófia Kokas(University of Szeged), Krisztina Bencsik(University of Szeged), Vanja Bašić Kes(Sisters of Charity Hospital), Achim Berthele, Bernhard Hemmer(TUM Klinikum), Anett Járdánházy(University of Szeged), Zsanett Fricska‐Nagy(University of Szeged), Cristina Tiu(Clinical Emergency Hospital Bucharest), László Vécsei(University of Szeged), Halina Bartosik-Psujek(University of Rzeszów), Tamás Biernacki(University of Szeged), Alenka Horvat Ledinek(Ljubljana University Medical Centre), Péter Klivènyi(University of Szeged), Thomas Berger(Medical University of Vienna), Konrad Rejdak(Medical University of Lublin), Zsigmond Tamás Kincses(University of Szeged), Eva Havrdová(Charles University), Jelena Drulović(University of Belgrade), Judit Füvesi(University of Szeged), Dániel Sandi(University of Szeged), Dana Horáková(Charles University), Peter Turčáni(University Hospital Bratislava), Melinda Magyari(University of Copenhagen)
Cited by 5
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
|New England Journal of Medicine|2016|1.9k
Multiple sclerosis
|The Lancet|2018|1.8k